I would imagine it's rBST that you're talking about. It's a drug approved in the U.S. It hasn't been approved in Canada. Obviously the concern when we looked at this particular drug was not human health but concern in terms of animal health. Therefore, the drug was not approved for use. The drug is also not approved for use in Europe and many other countries.
It's very important to remember that the door is always open for industry to come in with studies that will justify why the concerns Health Canada has raised can be alleviated. So as a drug company, if you were developing rBST or any other drug, you would file a submission. We would provide you with comments as to the reasons this particular product is not approvable and that additional studies would be required, or for you to be able to justify the rationale for that particular drug to be on the market.
Therefore, at this point in time, rBST is not a product that's approved for use in Canada because of animal health concerns, certainly not human health concerns. But there is no reason why, if the company had additional studies to justify our having a rethink, a re-examination of the information that's available, there wouldn't be an opportunity to reconsider any submission, not just rBST.